SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zenotech Laboratorie - Quaterly Results

30 Apr 2026 Evaluate
Net sales declined -18.55%  to  Rs. 98.81 million from Rs. 121.31 millions.The Net Loss for the quarter ended March 2026 is Rs. -31.50 millions as compared to Net Profit of Rs. 12.29 millions of corresponding quarter ended March 2025Operating profit for the quarter ended March 2026 decreased to 7.69 millions as compared to 49.62 millions of corresponding quarter ended March 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 98.81 121.31 -18.55 436.14 430.47 1.32 436.14 430.47 1.32
Other Income 5.96 4.93 20.89 23.09 15.49 49.06 23.09 15.49 49.06
PBIDT 7.69 49.62 -84.50 114.98 157.29 -26.90 114.98 157.29 -26.90
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 8.23 49.13 -83.25 113.03 176.52 -35.97 113.03 176.52 -35.97
Depreciation 17.58 17.27 1.80 71.13 69.60 2.20 71.13 69.60 2.20
PBT -9.35 31.86 -129.35 41.90 106.92 -60.81 41.90 106.92 -60.81
TAX 22.15 19.57 13.18 52.61 50.79 3.58 52.61 50.79 3.58
Deferred Tax -1.79 -5.36 -66.60 47.72 25.86 84.53 47.72 25.86 84.53
PAT -31.50 12.29 -356.31 -10.71 56.13 -119.08 -10.71 56.13 -119.08
Equity 610.31 610.31 0.00 610.31 610.31 0.00 610.31 610.31 0.00
PBIDTM(%) 7.78 40.90 -80.97 26.36 36.54 -27.85 26.36 36.54 -27.85

Zenotech Laboratorie Share Price

43.40 -0.62 (-1.41%)
05-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1820.75
Dr. Reddys Lab 1270.95
Cipla 1333.55
Zydus Lifesciences 911.85
Lupin 2343.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×